American Journal of Neuroradiology 20:1543-1546 (9 1999)
© 1999 American Society of Neuroradiology
ARTICLE
Barbiturate Anesthesia and Brain Proton Spectroscopy
a From the Departments of Radiology (N.M.I.L., M.K.) and Anesthesia (T.M., K.A.L., O.A.K.), and the Central Laboratory (O.P.), Turku University Hospital, Kiinanmyllynkatu 48, FIN-20520 Turku, Finland.
BACKGROUND AND PURPOSE: Thiopentone reduces CBF and metabolic rate. Still, it is widely used for sedation during MR spectroscopy. We investigated whether barbiturate anesthesia and preanesthetic fasting have an effect on metabolic ratios in proton MR spectroscopy of the brain.
METHODS: Eight healthy, consenting, male volunteers were studied twice in a random, crossover fashion. The study sessions were conducted during fasting (F) and nonfasting (nonF), with glucose infusion mimicking the fed state. During both sessions, two sets of spectroscopic data were collected, one during the awake state (F or nonF) and one under barbiturate anesthesia (F+B or nonF+B), using TEs of 135 and 270. Spectral areas of N-acetylaspartate (NAA), choline-containing compounds (Cho), and creatine plus phosphocreatine (Cr) were calculated, and the presence of lactate or lipid was noted. Venous blood samples for glucose, ß-hydroxybutyrate, lactate, and electrolytes were collected.
RESULTS: Barbiturate anesthesia caused a 42% reduction in blood lactate levels during fasting, but not during glucose infusion. There were no differences in NAA/Cho, NAA/Cr, or in Cho/Cr between the groups F, nonF, F+B, or nonF+B. No lactate or lipid resonances were detected.
CONCLUSION: Barbiturate anesthesia with preanesthetic fasting can be used for proton spectroscopy at TEs of 135 or 270 without interference from NAA/Cho, NAA/Cr, or Cho/Cr or from the appearance of lactate or lipid.
This article has been cited by other articles:
![]() |
W. Kulak, W. Sobaniec, J. Smigielska-Kuzia, B. Kubas, B. Zawada, and D. Otapowicz An Age and Gender Dependency of Metabolite Concentrations in Basal Ganglia in Children with Spastic Diplegia: Proton Magnetic Resonance Spectroscopy Study J Child Neurol, January 1, 2009; 24(1): 73 - 79. [Abstract] [PDF] |
||||
![]() |
Z.J. Wang, D.B. Vigneron, S.P. Miller, P. Mukherjee, N.N. Charlton, Y. Lu, and A.J. Barkovich Brain Metabolite Levels Assessed by Lactate-Edited MR Spectroscopy in Premature Neonates with and without Pentobarbital Sedation AJNR Am. J. Neuroradiol., April 1, 2008; 29(4): 798 - 801. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.D. Friedman, D.W. Shaw, A.A. Artru, T.L. Richards, J. Gardner, G. Dawson, S. Posse, and S.R. Dager Regional brain chemical alterations in young children with autism spectrum disorder Neurology, January 14, 2003; 60(1): 100 - 107. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bendszus, W. Reents, D. Franke, W. Mullges, J. Babin-Ebell, M. Koltzenburg, M. Warmuth-Metz, and L. Solymosi Brain Damage After Coronary Artery Bypass Grafting Arch Neurol, July 1, 2002; 59(7): 1090 - 1095. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Smith, L. Chang, M. L. Yonekura, K. Gilbride, J. Kuo, R. E. Poland, I. Walot, and T. Ernst Brain Proton Magnetic Resonance Spectroscopy and Imaging in Children Exposed to Cocaine in Utero Pediatrics, February 1, 2001; 107(2): 227 - 231. [Abstract] [Full Text] |
||||




